(firstQuint)A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma.

 This is a multicenter, open-label study to evaluate the safety and efficacy of Targretin capsules in patients with AIDS-related KS.

 NOTE: The daily dose may be reduced as necessary for toxicity management.

.

 A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma@highlight

The purpose of this study is to see if it is safe and effective to give Targretin capsules to patients with AIDS-related Kaposi's sarcoma (KS).

